44 results
8-K
EX-10.2
PYXS
Pyxis Oncology Inc
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
(including reimbursement of expenses) to the person making it.
(e)The indemnity agreements contained herein shall be in addition to (i) any cause of action
8-K
EX-10.1
PYXS
Pyxis Oncology Inc
28 Nov 23
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
7:22am
in the performance of your duties under this Agreement, all in accordance with the Company’s reimbursement policies.
c.Terms. As is the case of all employee … in which termination of employment occurs; (iii) reimbursement of any unreimbursed business expenses incurred as of the date of termination of employment
S-8 POS
EX-4.5
j2c 6snuipli
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
POS AM
EX-4.5
p80oc8q7ckgy3eka
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm
S-8
EX-4.5
8nk3zxh7 9zklgi3
23 Aug 23
Registration of securities for employees
5:28pm
424B3
84ncp6 ici0gk
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
1bji81e 0t4aojm2
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
hdyrm
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
94c5f3bor5 9z81
24 May 23
Business combination disclosure
7:05am
425
pmfub
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
qej82fm
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
S-3
a1q2b67i3n0 4i8i
1 Nov 22
Shelf registration
4:51pm